Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04119336
Title Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Andrew Yee, MD
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.